持续追踪国内外重要财经与资本事件。
The uni’s Genesis Pre-Seed Fund and OG VC Uniseed backed R2Crete, which turns waste concrete into clean aggregates and cement replacement.
Watch as Neko Health Investor Farooq Abbasi joins Equity to explain the bet on preventative healthcare, competition and what comes next.
Daniel Ek’s Neko Health raised $700M to bring body scanning to the U.S. Investor Farooq Abbasi joins Equity to explain the bet on preventative healthcare, competition and what comes next.
美国肿瘤细胞治疗服务商Link Cell Therapies宣布完成A+轮融资，多家知名投资机构参与。
美国房地产对话式AI平台EliseAI宣布完成新一轮战略融资，投资方包括a16z、BVP等知名机构。
BAG Ventures announces close of a $11.3M Fund I to invest in all things AI.
Homegrown new-age tech ventures raised $2.2 Bn between July and September, up 5% from the $2.1 Bn raised in the year-ago quarter
E2W manufacturer Simple Energy has raised $180 Mn (₹1,750 Cr) in its Series C funding round led by Dr. Arokiaswamy Velumani Family Office
September saw Indian startups raise $760.7 Mn across 210 deals, as AI, deeptech, public markets and new pools of capital dominated India’s startup ecosystem.
Aqua Medical是一家临床阶段微创内镜代谢疗法器械研发商，基于蒸气的内窥镜消融技术，开发 PIMA 经内镜十二指肠消融技术治疗 2 型糖尿病，旨在治疗胃肠道疾病和预防胃肠癌。近日，Aqua Medical宣布完成B轮融资，由田纳西州纳什维尔的Relevance Ventures领投。资金将用于完成正在进行的美国RESTORE-1初步研究，并为计划中的美国关键性试验进行运营准备。
Reverion是一家德国沼气发电技术研发商，专注于研发沼气发电技术研发，解决了与沼气发电相关的历史技术缺陷，使用户从相同数量的生物质中获得的收入。近日，Reverion宣布完成1.75亿美元B轮融资，资金将用于建设全新年产 250MW 生产基地，规模化生产可逆式能源系统。该设备可在高效发电与固体氧化物制氢两种工况之间灵活切换。
荷兰汽车消费决策AI平台CarIX.AI完成种子轮融资，将加速智能决策平台研发。
The VC targets an exit from investments within around five years, backing founders seeking to build and sell businesses worth $200-500m.
三友联众是一家继电器提供商，集研发、生产、销售、服务于一体，为用户提供磁保持继电器、通用功率继电器、汽车继电器、新能源继电器等产品，应用于家电、交通、工业等领域。三友联众公告，公司拟向不特定对象发行可转换公司债券，募集资金总额不超过6.6亿元，扣除发行费用后将用于信号继电器扩产及产业化建设项目、光伏、储能及算力领域继电器扩产建设项目、越南生产基地建设项目、磁保持继电器扩产建设项目及补充流动资金。
AI-driven edtech startup Arivihan raised $10.2 Mn in its Series A funding round co-led by existing backers Accel and Prosus Ventures.
EliseAI raises $350M, doubles valuation in a year.
美国保险AI平台Outmarket AI完成B轮融资，由多家知名基金联合投资。
阿斯利康宣布战略投资英国肌营养不良药物研发商Summit Therapeutics，双方将共同推进肌营养不良症治疗药物的研发。